Skip to main content
Figure 3 | Clinical Proteomics

Figure 3

From: Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue

Figure 3

SRM analysis for EGFR in FFPE tumor specimens taken from patients with non-small cell lung carcinoma (NSCLC) after treatment with the EGFR inhibitor gefitinib in the neoadjuvant setting. SRM analysis across a cohort of formalin fixed tumor specimens demonstrates EGFR quantitation across a broad range of EGFR expression levels after treatment with gefitinib.

Back to article page

Clinical Proteomics

ISSN: 1559-0275